Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Needham Has Started Coverage on Teleflex (NYSE:TFX) Stock with Buy Rating and $221.0 Target

Needham Analyst Rating Change Teleflex NYSE:TFX

Teleflex (NYSE:TFX) Price Target & New Coverage by Needham

Analysts at Needham has begun coverage on shares of Teleflex (NYSE:TFX) in a research report issued to clients and investors on 7 March. The company set Buy rating on the $8.68 billion market cap company.

Despite the new coverage NYSE:TFX is at the moment trading -0.69% lower at $193.01 as of 10:07 PM New York time. Teleflex shares have [From2] 0% over the past 200 days, while the S&P500 has risen 16.00% during the same time period.

According to data compiled by Thomson Reuters, Teleflex (NYSE:TFX)’s Stock is covered by 11 equity analysts across the Street, with 0 analysts giving it a Sell rating, 9 a Buy rating, while 3 consider it a Hold. The 12-month consensus target price for the stock is $167.36, which reflects an downside potential of 13.29% over the current price.

Institutional Ownership

Solaris Asset Management Llc had the largest stake with ownership of 28,224 shares as of Q2 2015 for 2.99% of the equity exposure. Mountain Pacific Investment Advisers Inc Id is another very bullish investment manager who is having 139,998 shares of Teleflex or 2.63% of their equity exposure. Furthermore, New South Capital Management Inc have 2.56% of their equity exposure invested in the company for 636,088 shares. The California-based fund Fairview Capital Investment Management Llc revealed it had acquired a stake worth about 2.48% of the investment manager’s stock portfolio in Teleflex. The Georgia-based fund Atlanta Capital Management Co L L C is also positive about the stock, possessing 193,163 shares or 2.17% of their equity exposure.

Teleflex (NYSE:TFX) Profile

Teleflex IncTeleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

Teleflex (NYSE:TFX) traded down -0.69% on 7 March, hitting $193.01. A total of 228,999 shares of the company’s stock traded hands. This is down from average of 260,999 shares. Teleflex has a 52 week low of $136.53 and a 52 week high of $198.89. The company has a market cap of $8.68 billion and a P/E ratio of 38.72.

Get the latest Teleflex (NYSE:TFX) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Needham Has Started Coverage on Teleflex (NYSE:TFX) Stock with Buy Rating and $221.0 Target appeared first on Octafinance.

This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Needham Has Started Coverage on Teleflex (NYSE:TFX) Stock with Buy Rating and $221.0 Target


Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription